News Focus
News Focus
Post# of 257579
Next 10
Followers 9
Posts 1369
Boards Moderated 0
Alias Born 04/26/2004

Re: 10nisman post# 111373

Thursday, 12/23/2010 12:05:13 PM

Thursday, December 23, 2010 12:05:13 PM

Post# of 257579
So Teva is using the FDA's complete response letter as evidence that MNTA's copaxone can not be approved without clinical trials.

Apparently, the market is buying it.

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today